118 related articles for article (PubMed ID: 38935733)
1. A neutralizing antibody prevents postfusion transition of measles virus fusion protein.
Zyla DS; Della Marca R; Niemeyer G; Zipursky G; Stearns K; Leedale C; Sobolik EB; Callaway HM; Hariharan C; Peng W; Parekh D; Marcink TC; Diaz Avalos R; Horvat B; Mathieu C; Snijder J; Greninger AL; Hastie KM; Niewiesk S; Moscona A; Porotto M; Ollmann Saphire E
Science; 2024 Jun; 384(6703):eadm8693. PubMed ID: 38935733
[TBL] [Abstract][Full Text] [Related]
2. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
Palomo C; Mas V; Thom M; Vázquez M; Cano O; Terrón MC; Luque D; Taylor G; Melero JA
J Virol; 2016 Jun; 90(11):5485-5498. PubMed ID: 27009962
[TBL] [Abstract][Full Text] [Related]
3. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein.
Huang J; Chopra P; Liu L; Nagy T; Murray J; Tripp RA; Boons GJ; Mousa JJ
J Virol; 2021 Aug; 95(18):e0059321. PubMed ID: 34160259
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.
Swanson KA; Settembre EC; Shaw CA; Dey AK; Rappuoli R; Mandl CW; Dormitzer PR; Carfi A
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9619-24. PubMed ID: 21586636
[TBL] [Abstract][Full Text] [Related]
5. The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane.
Fontana J; Atanasiu D; Saw WT; Gallagher JR; Cox RG; Whitbeck JC; Brown LM; Eisenberg RJ; Cohen GH
mBio; 2017 Aug; 8(4):. PubMed ID: 28830949
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
Stewart-Jones GBE; Chuang GY; Xu K; Zhou T; Acharya P; Tsybovsky Y; Ou L; Zhang B; Fernandez-Rodriguez B; Gilardi V; Silacci-Fregni C; Beltramello M; Baxa U; Druz A; Kong WP; Thomas PV; Yang Y; Foulds KE; Todd JP; Wei H; Salazar AM; Scorpio DG; Carragher B; Potter CS; Corti D; Mascola JR; Lanzavecchia A; Kwong PD
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12265-12270. PubMed ID: 30420505
[TBL] [Abstract][Full Text] [Related]
7. Clinical Potential of Prefusion RSV F-specific Antibodies.
Rossey I; McLellan JS; Saelens X; Schepens B
Trends Microbiol; 2018 Mar; 26(3):209-219. PubMed ID: 29054341
[TBL] [Abstract][Full Text] [Related]
8. Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
Más V; Rodriguez L; Olmedillas E; Cano O; Palomo C; Terrón MC; Luque D; Melero JA; McLellan JS
PLoS Pathog; 2016 Sep; 12(9):e1005859. PubMed ID: 27611367
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
Cairns TM; Fontana J; Huang ZY; Whitbeck JC; Atanasiu D; Rao S; Shelly SS; Lou H; Ponce de Leon M; Steven AC; Eisenberg RJ; Cohen GH
J Virol; 2014 Mar; 88(5):2677-89. PubMed ID: 24352457
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation.
Blais N; Gagné M; Hamuro Y; Rheault P; Boyer M; Steff AM; Baudoux G; Dewar V; Demers J; Ruelle JL; Martin D
J Virol; 2017 Jul; 91(13):. PubMed ID: 28404847
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.
Banerjee A; Huang J; Rush SA; Murray J; Gingerich AD; Royer F; Hsieh CL; Tripp RA; McLellan JS; Mousa JJ
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2203326119. PubMed ID: 35696580
[TBL] [Abstract][Full Text] [Related]
12. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein.
Mousa JJ; Kose N; Matta P; Gilchuk P; Crowe JE
Nat Microbiol; 2017 Jan; 2():16271. PubMed ID: 28134924
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein.
Mousa JJ; Sauer MF; Sevy AM; Finn JA; Bates JT; Alvarado G; King HG; Loerinc LB; Fong RH; Doranz BJ; Correia BE; Kalyuzhniy O; Wen X; Jardetzky TS; Schief WR; Ohi MD; Meiler J; Crowe JE
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6849-E6858. PubMed ID: 27791117
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
Patel N; Massare MJ; Tian JH; Guebre-Xabier M; Lu H; Zhou H; Maynard E; Scott D; Ellingsworth L; Glenn G; Smith G
Vaccine; 2019 Sep; 37(41):6112-6124. PubMed ID: 31416644
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of respiratory syncytial virus neutralization by motavizumab.
McLellan JS; Chen M; Kim A; Yang Y; Graham BS; Kwong PD
Nat Struct Mol Biol; 2010 Feb; 17(2):248-50. PubMed ID: 20098425
[TBL] [Abstract][Full Text] [Related]
18. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.
McGinnes Cullen L; Schmidt MR; Kenward SA; Woodland RT; Morrison TG
J Virol; 2015 Jul; 89(13):6835-47. PubMed ID: 25903340
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.
McLellan JS
Curr Opin Virol; 2015 Apr; 11():70-5. PubMed ID: 25819327
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies.
Mishra AK; Hellert J; Freitas N; Guardado-Calvo P; Haouz A; Fels JM; Maurer DP; Abelson DM; Bornholdt ZA; Walker LM; Chandran K; Cosset FL; McLellan JS; Rey FA
Science; 2022 Jan; 375(6576):104-109. PubMed ID: 34793197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
